Samantha Macphail, NP
Dermatology · Brooklyn, NYNPI 1831734565
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 385 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,243, 4.8 times the $466 reported in 2021.
Across 385 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$986
- Lilly USA, LLC$828
- Novartis$731
- Sanofi$608
- Galderma Laboratories, L.p.$557
- Johnson & Johnson$556
- plus $3K from 20 others
What the payments were for
- Food & beverage$6,97295%
- Education$3615%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $986 |
| Lilly USA, LLC | 56 | $828 |
| Novartis | 35 | $731 |
| Sanofi | 19 | $608 |
| Galderma Laboratories, L.p. | 23 | $557 |
| Johnson & Johnson | 20 | $556 |
| Incyte Corporation | 31 | $499 |
| Regeneron Healthcare Solutions, Inc. | 21 | $422 |
| Journey Medical Corporation | 12 | $282 |
| Amgen | 12 | $278 |
| LEO Pharma Inc. | 16 | $246 |
| E.r. Squibb & Sons, L.L.C. | 13 | $185 |
| Mayne Pharma Commercial LLC | 13 | $184 |
| Verrica Pharmaceuticals Inc. | 2 | $132 |
| Organon | 5 | $130 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $104 |
| Dermavant Sciences, Inc. | 7 | $104 |
| Sun Pharmaceutical Industries Inc. | 6 | $100 |
| Sanofi-aventis U.S. LLC | 1 | $92 |
| Arcutis Biotherapeutics, Inc. | 4 | $60 |
| Biofrontera Inc. | 4 | $58 |
| EPI Health, LLC | 2 | $54 |
| Pfizer | 3 | $54 |
| UCB, Inc. | 3 | $53 |
| Almirall LLC | 1 | $17 |
| LNHC, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,333 in reported general payments places this provider in the 70th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $49,240 |
| Clobetasol Propionate | 51 | $2,396 |
| Tacrolimus | 11 | $2,257 |
| Ketoconazole | 52 | $1,184 |
| Triamcinolone Acetonide | 66 | $851 |
| Clindamycin Phosphate | 14 | $439 |
| Mupirocin | 38 | $263 |
| Hydrocortisone | 35 | $129 |
| Doxycycline Hyclate | 17 | $98 |
| Hydroxyzine Hcl | 14 | $69 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Brooklyn
- Hilary BaldwinBrooklyn$1.5M
- Steven BaranowitzBrooklyn$625K
- Susan BardBrooklyn$425K
- Nanette SilverbergBrooklyn$337K
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.